Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$6.1 - $10.41 $1,067 - $1,821
175 New
175 $1,000
Q2 2019

Aug 02, 2019

BUY
$20.52 - $26.45 $4,740 - $6,109
231 Added 24.89%
1,159 $29,000
Q1 2019

May 09, 2019

BUY
$20.23 - $26.29 $202 - $262
10 Added 1.09%
928 $23,000
Q4 2018

Feb 06, 2019

BUY
$17.64 - $28.32 $423 - $679
24 Added 2.68%
918 $17,000
Q3 2018

Nov 05, 2018

BUY
$20.64 - $25.67 $18,452 - $22,948
894 New
894 $23,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Alpha Mark Advisors, LLC Portfolio

Follow Alpha Mark Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.